Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06516588 · ClinicalTrials.gov registry record · Phase 2

tDCS for Post-Stroke Cognitive Impairment

A Phase 2 study of Stroke and Mild Cognitive Impairment, sponsored by University of Oklahoma.

Recruiting
Registry status
Phase 2
Development phase
80
Enrollment target
1
Study location

NCT06516588: Recruiting Phase 2 study of Stroke and Mild Cognitive Impairment, sponsored by University of Oklahoma.

NCT06516588 is a Phase 2 study of Stroke and Mild Cognitive Impairment that is actively recruiting participants, run by University of Oklahoma. The registered enrollment target is 80 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06516588, a Phase 2 study of Stroke and Mild Cognitive Impairment, is actively recruiting participants, sponsored by University of Oklahoma.

RECRUITING
Registry status
Phase 2
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the effects of a form of non-invasive brain stimulation on brain functioning and memory in participants with post-stroke cognitive impairment (PSCI).

Primary Outcome

It is a 30-point test about several cognitive domains (visuospatial/executive, naming, memory, attention, language, abstraction, delayed recall and orientation) and a screening tool used of MCI and dementia.

Conditions Studied

Stroke Mild Cognitive Impairment

Interventions

  • DEVICE Transcranial Dirrect Current Stimulation

Study Locations (1)

Oklahoma

  • University of Oklahoma - Oklahoma City

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2024-09-30
Est. Completion 2027-06-30
Phase Phase 2
University of Oklahoma

358 total trials

What NCT06516588 shows while recruiting

NCT06516588 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Transcranial Dirrect Current Stimulation is the first listed.

NCT06516588 reports a single indexed study location in Oklahoma.

Frequently Asked Questions

What is clinical trial NCT06516588 about?

NCT06516588 is a clinical study titled "tDCS for Post-Stroke Cognitive Impairment". This study will evaluate the effects of a form of non-invasive brain stimulation on brain functioning and memory in participants with post-stroke cognitive impairment (PSCI).

What is the current status of trial NCT06516588?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 80 participants. The study started on 2024-09-30. Estimated completion is 2027-06-30.

What conditions does trial NCT06516588 study?

This clinical trial studies the following conditions: Stroke, Mild Cognitive Impairment.

What interventions are being tested in trial NCT06516588?

The interventions under investigation include: Transcranial Dirrect Current Stimulation (DEVICE).

Who is sponsoring clinical trial NCT06516588?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06516588 being conducted?

This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06516588's enrollment target sits among peer trials

80 167th of 454 higher than 282 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06516588

Source: ClinicalTrials.gov NCT06516588, the US trial registry maintained by the National Library of Medicine. NCT06516588 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.